FDA Perspective on Developing Novel Combination Therapies – What We Need
Increasingly it has become obvious to me and to many other individuals that our current drug approval and development process has a basic flaw. If you go to research conferences you quickly learn that there [...]
Study Results Provide Evidence for First-Line Use of Firmagon (degarelix) in Advanced Prostate Cancer
Firmagon, the newly FDA approved gonadotropin-releasing hormone (GnRH) receptor blocker should perhaps be considered as a better alternative to the traditionally used ADT drugs like lupron and zoladex (GnRH agonists) which are the current standard [...]
Zoledronic Acid Also Induces Cell Death in Human Prostate Cancer Cells
Bisphosphonates, specifically Zometa, is commonly used in the treatment of men with advanced prostate cancer. Zometa is used to treat and protect bones from developing fractures. Bisphosphonates are potent inhibitors of bone resorption. Additionally, in [...]
Signs of A Stroke You Should Know – STRT
Stroke is an all too common disabling event and killer. As we age and as we go through the various treatments to fight our advanced prostate cancer our risks for a stroke only increase. Neurologists [...]
More Good Data Supporting the Approval of Abiraterone
As we all anxiously wait for the FDA to finally make a determination about the pending application for approval of the investigational androgen biosynthesis inhibitor abiraterone acetate more data rolls in showing that supports the [...]
Fighting Cancer Is a Defense Department Obligation
Posted: March 18, 2011 10:24 AM : The Huffington Post "At last week's Innovative Minds in Prostate Cancer meeting, the speakers included not only doctors, but patients. We patients also help review the grant applications [...]